Evidence map›Paper›PMID 26895884›Full record

ArticleDiabetes care2016

Branched-Chain Amino Acids and Insulin Metabolism: The Insulin Resistance Atherosclerosis Study (IRAS).

C Christine Lee, Steve M Watkins, Carlos Lorenzo, Lynne E Wagenknecht, Dora Il'yasova, Yii-Der I Chen, Steven M Haffner, Anthony J Hanley

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes care, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
10.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it, 170 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. The Complex Relation of Branched-Chain Amino Acids and Inflammation in the Obesity and Diabetes Context.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Metabolomics: Uncovering Insights into Obesity and Diabetes.International journal of molecular sciences · 2025
    Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 2 countries.

C Christine LeeDepartment of Nutritional Sciences, University of Toronto, Toronto, ON, Canada.
Steve M WatkinsLipomics Technologies, Inc., a division of Metabolon, Inc., West Sacramento, CA.
Carlos LorenzoDivision of Clinical Epidemiology, University of Texas Health Science Center, San Antonio, TX.
Lynne E WagenknechtDivision of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC.
Dora Il'yasovaSchool of Public Health, Georgia State University, Atlanta, GA.
Yii-Der I ChenInstitute for Translational Genomics and Population Sciences, Los Angeles Biomedical Research Institute, Torrance, CA.
Steven M HaffnerRetired, San Antonio, TX.
Anthony J HanleyDepartment of Nutritional Sciences, University of Toronto, Toronto, ON, Canada Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, ON, Canada anthony.hanley@utoronto.ca.
Georgia State University · USMetabolon (United States) · USMount Sinai Hospital · CAThe Lundquist Institute · USThe University of Texas Health Science Center at San Antonio · USUniversity of Toronto · CAWake Forest University · US

Funding

UCLA Clinical and Translational Science InstituteUL1TR000124 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI DUBINETT, STEVEN M. · 2012 to 2015
$57.0M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ALAN R. SALTIEL · 2003 to 2026
$40.4M
QUANTITATION OF FACTORS REGULATING GLUCOSE TOLERANCER01DK029867 · NIDDK · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MARILYN ADER · 1986 to 2026
$11.0M
Insulin Clearance: Candidate and Positional Genetic DeterminantsR01DK079888 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI GOODARZI, MARK · 2008 to 2012
$1.7M
INSULIN RESISTANCE AND CARDIOVASCULAR DISEASEU01HL047892 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI REWERS, MARIAN J. · 1991 to 1999
–
INSULIN RESISTANCE AND ATHEROSCLEROSIS STUDY (IRAS)U01HL047902 · NHLBI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SAAD, MOHAMMED F · 1991 to 1999
–
NCATS NIH HHS UL1 TR000124NHLBI NIH HHS U01 HL047892NHLBI NIH HHS U01 HL047902NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK029867NIDDK NIH HHS R01 DK079888
6 · The paper itself

Abstract

objectiveRecent studies using untargeted metabolomics approaches have suggested that plasma branched-chain amino acids (BCAAs) are associated with incident diabetes. However, little is known about the role of plasma BCAAs in metabolic abnormalities underlying diabetes and whether these relationships are consistent across ethnic populations at high risk for diabetes. We investigated the associations of BCAAs with insulin sensitivity (SI), acute insulin response (AIR), and metabolic clearance of insulin (MCRI) in a multiethnic cohort. RESEARCH DESIGN AND

methodsIn 685 participants without diabetes of the Insulin Resistance Atherosclerosis Study (IRAS) (290 Caucasians, 165 African Americans, and 230 Hispanics), we measured plasma BCAAs (sum of valine, leucine, and isoleucine) by mass spectrometry and SI, AIR, and MCRI by frequently sampled intravenous glucose tolerance tests.

resultsElevated plasma BCAAs were inversely associated with SI and MCRI and positively associated with fasting insulin in regression models adjusted for potential confounders (β = -0.0012 [95% CI -0.0018, -0.00059], P < 0.001 for SI; β = -0.0013 [95% CI -0.0018, -0.00082], P < 0.001 for MCRI; and β = 0.0015 [95% CI 0.0008, 0.0023], P < 0.001 for fasting insulin). The association of BCAA with SI was significantly modified by ethnicity, with the association only being significant in Caucasians and Hispanics. Elevated plasma BCAAs were associated with incident diabetes in Caucasians and Hispanics (multivariable-adjusted odds ratio per 1-SD increase in plasma BCAAs: 1.67 [95% CI 1.21, 2.29], P = 0.002) but not in African Americans. Plasma BCAAs were not associated with SI-adjusted AIR.

conclusionsPlasma BCAAs are associated with incident diabetes and underlying metabolic abnormalities, although the associations were generally stronger in Caucasians and Hispanics.

Indexed as

Insulin ResistanceAmino Acids, Branched-ChainAtherosclerosisBlack or African AmericanCohort StudiesDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlucose Tolerance TestHispanic or LatinoHumansIncidenceInsulinLinear ModelsMaleMiddle AgedAmino Acids, Branched-ChainInsulin

Identifiers

PMID26895884
PMCPMC4806771
OpenAlexW2309231815

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.